Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Cantor Fitzgerald
Fish and Richardson
Johnson and Johnson
Cerilliant
Accenture
Daiichi Sankyo
Federal Trade Commission

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VIGAMOX

« Back to Dashboard

Clinical Trials for Vigamox

Trial ID Title Status Sponsor Phase Summary
NCT00324168 Steroids for Corneal Ulcers Trial Completed Aravind Eye Hospitals, India Phase 4 The purpose of this study is to determine whether adding topical steroids improves the outcomes of bacterial corneal ulcers, especially visual acuity.
NCT00324168 Steroids for Corneal Ulcers Trial Completed Dartmouth-Hitchcock Medical Center Phase 4 The purpose of this study is to determine whether adding topical steroids improves the outcomes of bacterial corneal ulcers, especially visual acuity.
NCT00324168 Steroids for Corneal Ulcers Trial Completed Thomas M. Lietman Phase 4 The purpose of this study is to determine whether adding topical steroids improves the outcomes of bacterial corneal ulcers, especially visual acuity.
NCT00332293 AL-15469A for the Treatment of Bacterial Conjunctivitis Completed Alcon Research Phase 3 The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.
NCT00347828 Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose Unknown status Allergan Phase 4 The purpose of this study is to analyze the effect of Zymar and Vigamox on ocular surface bacteria. We believe that Zymar will eradicate more ocular surface bacteria than Vigamox.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Vigamox

Condition Name

Condition Name for Vigamox
Intervention Trials
Cataract Extraction 3
Eye Infections 3
Bacterial Infections 3
Bacterial Conjunctivitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Vigamox
Intervention Trials
Cataract 8
Eye Infections 5
Infection 4
Communicable Diseases 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Vigamox

Trials by Country

Trials by Country for Vigamox
Location Trials
United States 29
Israel 2
India 1
China 1
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Vigamox
Location Trials
Missouri 4
California 3
New York 3
Pennsylvania 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Vigamox

Clinical Trial Phase

Clinical Trial Phase for Vigamox
Clinical Trial Phase Trials
Phase 4 13
Phase 3 4
N/A 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Vigamox
Clinical Trial Phase Trials
Completed 14
Unknown status 5
Not yet recruiting 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Vigamox

Sponsor Name

Sponsor Name for Vigamox
Sponsor Trials
Alcon Research 4
Merck Sharp & Dohme Corp. 3
Stanford University 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Vigamox
Sponsor Trials
Other 19
Industry 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
UBS
Baxter
Medtronic
Argus Health
AstraZeneca
Teva
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.